20-HETE and EETs in Diabetic Nephropathy: A Novel Mechanistic Pathway

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Eid, Stephanie ^a   Maalouf, Rita ^b   Jaffa, Ayad A ^a   Nassif, Joseph ^a   Hamdy, Ahmed ^c   Rashid, Awad ^c   Ziyadeh, Fuad N ^a   Eid, Assaad A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b NOTRE DAME UNIVERSITY   (Lebanon)

^c HAMAD MEDICAL CORPORATION   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CYTOCHROME P450 2C11; CYTOCHROME P450 4A; EPOXYICOSATRIENOIC ACID; MAMMALIAN TARGET OF RAPAMYCIN; REACTIVE OXYGEN METABOLITE; S6 KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL SWELLING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HYPERGLYCEMIA; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

8,11,14-EICOSATRIENOIC ACID; ALKANE 1-MONOOXYGENASE; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; DIABETIC NEPHROPATHIES; GLUCOSE; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTROPHY; KIDNEY TUBULES, PROXIMAL; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; TOR SERINE-THREONINE KINASES;

EID: 84881002566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070029     Document Type: Article

References (66)

1. Gilbert RE, Cooper ME, (1999) The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56: 1627-1637.
2. Jones SC, Saunders HJ, Pollock CA, (1999) High glucose increases growth and collagen synthesis in cultured human tubulointerstitial cells. Diabet Med 16: 932-938.
3. Nath KA, (1998) The tubulointerstitium in progressive renal disease. Kidney Int 54: 992-994.
4. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, et al. (1995) Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944.
5. Schwartzman ML, da Silva JL, Lin F, Nishimura M, Abraham NG, (1996) Cytochrome P450 4A expression and arachidonic acid omega-hydroxylation in the kidney of the spontaneously hypertensive rat. Nephron 73: 652-663.
6. Kalsotra A, Cui X, Anakk S, Hinojos CA, Doris PA, Strobel HW, (2005) Renal localization, expression, and developmental regulation of P450 4F cytochromes in three substrains of spontaneously hypertensive rats. Biochem Biophys Res Commun 338: 423-431.
7. Ito O, Nakamura Y, Tan L, Ishizuka T, Sasaki Y, et al. (2006) Expression of cytochrome P-450 4 enzymes in the kidney and liver: regulation by PPAR and species-difference between rat and human. Mol Cell Biochem 284: 141-148.
8. Powell PK, Wolf I, Lasker JM, (1996) Identification of CYP4A11 as the Major Lauric Acid [omega]-Hydroxylase in Human Liver Microsomes. Arch Biochem Biophys 335: 219.
9. Christmas P, Jones JP, Patten CJ, Rock DA, Zheng Y, et al. (2001) Alternative Splicing Determines the Function of CYP4F3 by Switching Substrate Specificity. J Biol Chem 276: 38166-38172.
10. Imaoka S, Hashizume T, Funae Y, (2005) Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. Drug Metab Pharmacokinet 20: 478-484.
11. Enayetallah AE, French RA, Thibodeau MS, Grant DF, (2004) Distribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human Tissues. J Histochem Cytochem. 52: 447-454.
12. Holla VR, Adas F, Imig JD, Zhao X, Price E Jr, et al. (2001) Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci USA 98: 5211-5216.
13. Hoagland KM, Flasch AK, Roman RJ, (2003) Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats. Hypertension 42: 669-673.
14. Sarkis A, Roman RJ, (2004) Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Curr Drug Metab 5: 245-256.
15. Miyata N, Roman RJ, (2005) Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 41: 175-193.
16. Wang JS, Singh H, Zhang F, Ishizuka T, Deng H, et al. (2006) Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res 98: 962-969.
17. Dey A, Marc C, Kaesemeyer WH, Zaharis CZ, Stewart J, et al. (2004) Rofecoxib decreases renal injury in obese Zucker rats. Clin Sci 107: 561-570.
18. Enriquez A, Leclercq I, Farrell GC, Robertson G, (1999) Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats. Biochem Biophys Res Commun 255: 300-306.
19. Imaoka S, Shimojo N, Funae Y, (1988) Induction of renal cytochrome P-450 in hepatic microsomes of diabetic rats. Biochem Biophys Res Commun 152: 680-687.
20. Craven PA, Patterson MC, DeRubertis FR, (1988) Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37: 429-435.
21. Rosello-Catafau J, Hotter G, Closa D, Ortiz MA, Pou-Torello JM, et al. (1994) Liver lipoxygenase arachidonic acid metabolites in streptozotocin-induced diabetes in rats. Prostaglandins Leukot Essent Fatty Acids 51: 411-413.
22. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, et al. (2009) Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 58: 1201-1211.
23. McCarthy ET, Sharma R, Sharma M, (2005) Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier. Kidney Int 67: 152-156.
24. Dahly-Vernon AJ, Sharma M, McCarthy ET, Savin VJ, Ledbetter SR, et al. (2005) Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats. Hypertension 45: 643-648.
25. Chen G, Wang P, Zhao G, Xu G, Gruzdev A, et al. (2011) Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice. Prostaglandins Other Lipid Mediat 96: 63-71.
26. Ha H, Lee HB (2000) Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int 77 (Suppl): S19-25.
27. Brownlee M, (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
28. Kuroki T, Isshiki K, King GL, (2003) Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol 14 (8Suppl 3): S216-220.
29. Puntarulo S, Cederbaum AI, (1998) Production of Reactive Oxygen Species by Microsomes Enriched in Specific Human Cytochrome P450 Enzymes. Free Radical Biol Med 24: 1324-1330.
30. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, et al. (2001) Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88: 44-51.
31. Hoagland KM, Maier KG, Roman RJ, (2003) Contributions of 20-HETE to the Antihypertensive Effects of Tempol in Dahl Salt-Sensitive Rats. Hypertension 41: 697-702.
32. New DD, Block K, Bhandhari B, Gorin Y, Abboud HE, (2012) IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells. Am J Physiol Cell Physiol 302: C122-30.
33. Chen P, Guo M, Wygle D, Edwards PA, Falck JR, et al. (2005) Inhibitors of cytochrome P450 4A suppress angiogenic responses. AM J Pathol 166: 615-624.
34. Williams JM, Sharma M, Anjaiahh S, Falck JR, Roman RJ, (2007) Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier. Am J Physiol Renal Physiol 293: F501-505.
35. Eid AA, Ford BM, Block K, Kasinath BS, Gorin Y, et al. (2010) AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem 285: 37503-37512.
36. Nilakantan V, Maenpaa C, Jia G, Roman RJ, Park F, (2008) 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells. Am J Physiol Renal Physiol 294: 562-570.
37. Mahimainathan L, Das F, Venkatesan B, Choudhury GG, (2006) Mesangial cell hypertrophy by high glucose is mediated by downregulation of the tumor suppressor PTEN. Diabetes 55: 2115-2125.
38. Senthil D, Choudhury GG, Abboud HE, Sonenberg N, Kasinath BS, (2002) Regulation of protein synthesis by IGF-I in proximal tubular epithelial cells. Am J Physiol Renal Physiol 283: F1226-1236.
39. Martignoni M, Groothuis GMM, De Kanter R, (2006) Species differences between mouse, rat, dog, monkey and human cytochrome P450-mediated drug metabolism. Expert Opin Drug Metab Toxicol 2: 875-894.
40. Allen DA, Harwood S, Varagunam M, Raftery MJ, Yaqoob MM, (2003) High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB Journal. 17: 908-910.
41. Park SH, Choi HJ, Lee JH, Woo CH, Kim JH, et al. (2001) High glucose inhibits renal proximal tubule cell proliferation and involves PKC, oxidative stress, and TGF-β1. Kidney Int 59: 1695-1705.
42. Hall PM (2006) Prevention of progression in diabetic nephropathy. Diabetes Spectr 19: 18-24.
43. Liu F, Wei CC, Wu SJ, Chenier I, Zhang SL, et al. (2009) Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int 75: 156-166.
44. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, et al. (2003) Angiotensin II induces apoptosis in renal proximaltubular cells. Am J Physiol 284: 955-965.
45. Brezniceanu ML, Liu F, Wei CC, Tran S, Sachetelli S, et al. (2007) Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int 71: 912-923.
46. Barnes JL, Gorin Y, (2011) Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int 79: 944-956.
47. Rhyu DY, Park J, Sharma BR, Ha H, (2012) Role of reactive oxygen species in transforming growth factor-beta1-induced extracellular matrix accumulation in renal tubular epithelial cells. Transplant Proc 44: 625-628.
48. Shah AM, Channon KM, (2004) Free radicals and redox signaling in cardiovascular disease. Heart 90: 486-487.
49. Natarajan R, Reddy MA, (2003) HETEs/EETs in renal glomerular and epithelial cell function. Curr Opin Pharmacol 3: 198-203.
50. Zeng Q, Han Y, Bao Y, Li W, Li X, et al. (2010) 20-HETE increases NADPH oxidase-derived ROS production and stimulates the L-type Ca2+channel via a PKC-dependent mechanism in cardiomyocytes. Am J Physiol Heart Circ Physiol 299: 1109-1117.
51. Williams JM, Sharma M, Anjaiahh S, Falck JR, Roman RJ, (2007) Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier. Am J Physiol Renal Physiol 293: 501-505.
52. Nieves D, Moreno JJ, (2007) Epoxyeicosatrienoic acids induce growth inhibition and calpain/caspase-12 dependent apoptosis in PDGF cultured 3T6 fibroblast. Apoptosis. 12: 1979-1988.
53. Liu L, Chen C, Gong W, Li Y, Edin ML, et al. (2011) Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide. J Pharmacol Exp Ther 339: 451-463.
54. Liu Y, Webb HK, Fukushima H, Micheli J, Markova S, et al. (2012) Attenuation of ciplatininduced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling. J Pharmacol Exp Ther 341: 725-734.
55. Chen G, Xu R, Wang Y, Wang P, Zhao G, et al. (2012) Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Endocrinol Metab 303: E563-575.
56. Chen G, Wang P, Zhao G, Xu G, Gruzdev A, et al. (2011) Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice. Prostaglandins Other Lipid Mediat 96: 63-71.
57. Lloberas N, Cruzado JM, Franquesa M, Herrero-Fresneda I, Torras J, et al. (2006) Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J Am Soc Nephrol 17: 1395-1404.
58. Yang Y, Wang J, Qin L, Shou Z, Zhao J, et al. (2007) Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 27: 495-502.
59. Flaquer M, Lloberas N, Franquesa M, Torras J, Vidal A, et al. (2010) The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in rats. Life Sci 87: 147-153.
60. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, et al. (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39: 1116-1124.
61. Helvig C, Dishman E, Capdevilla JH, (1998) Molecular, enzymatic, and regulatory characterization of rat kidney cytochrome P450 4A2 and 4A3. Biochemistry 37: 12546-12558.
62. Nakagawa K, Marji JS, Schwartzman ML, Waterman MR, Capdevila JH, (2003) Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension. Am J Physiol Regul Integr Comp Physiol 284: R1055-R1062.
63. Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, Gonzalez FJ, (2000) Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem 275: 40504-40510.
64. Singh H, Schwartzman ML, (2008) Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension. Pharmacol Rep 60: 29-37.
65. Singh H, Cheng J, Deng H, Kemp R, Ishizuka T, et al. (2007) Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension. Hypertension 50: 123-129.
66. Zhou Y, Lin S, Chang HH, Du J, Dong Z, et al. (2005) Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet. Am J Hypertens 18 (4 Pt 1): 530-537.